All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-MLH1 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-2290-FY | CBFYM-0063 | Mouse | Human | IgG1, k | Human MLH1 | |
DMAb-2291-FY | CBFYM-0311 | Rabbit | Human | IgG | ||
DMAb-2292-FY | CBFYM-0656 | Mouse | Human | IgG1, k | ||
DMAb-2293-FY | CBFYM-2286 | Mouse | Human | IgG1 | KLH conjugated synthetic peptide between 458-489 amino acids from the Central region of human MLH1 | |
DMAb-2294-FY | CBFYM-2287 | Mouse | Human | IgG1 | ||
DMAb-2295-FY | CBFYM-2288 | Mouse | Human | IgG2b | This antibody detects endogenous levels of MLH1 and does not cross-react with related proteins | |
DMAb-2296-FY | CBFYM-2289 | Mouse | Human | Recombinant full length Human MLH1 | ||
DMAb-2297-FY | CBFYM-2290 | Mouse | Human | IgG, κ | Full length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. | |
DMAb-2298-FY | CBFYM-2291 | Mouse | Human | IgG1, k | Recombinant full length protein (Human) | |
DMAb-2299-FY | CBFYM-2292 | Mouse | Human | IgG2a, k | Recombinant protein derived from the C-terminal region of the human MLH1 protein | |
DMAb-2300-FY | CBFYM-2293 | Mouse | Human | IgG1 | Recombinant fragment of MLH1 (aa381-483) expressed in E. coli | |
DMAb-2301-FY | CBFYM-2294 | Rabbit | Human | IgG | Synthetic peptide corresponding to residues near the amino terminus of human MLH1 protein (KLH coupled) |
There are currently no customer reviews or questions for Anti-MLH1 DNA-encoded mAb (DMAb), pVAX1 (DMAb-2290-FY). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION